3.54
price down icon3.80%   -0.14
after-market Handel nachbörslich: 3.50 -0.04 -1.13%
loading
Schlusskurs vom Vortag:
$3.68
Offen:
$3.65
24-Stunden-Volumen:
106.16K
Relative Volume:
0.04
Marktkapitalisierung:
$10.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.97M
KGV:
-0.9095
EPS:
-3.8923
Netto-Cashflow:
$-6.79M
1W Leistung:
+1.14%
1M Leistung:
+162.22%
6M Leistung:
-17.29%
1J Leistung:
-44.69%
1-Tages-Spanne:
Value
$3.43
$3.78
1-Wochen-Bereich:
Value
$3.36
$3.89
52-Wochen-Spanne:
Value
$1.3259
$21.00

Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile

Name
Firmenname
Acurx Pharmaceuticals Inc
Name
Telefon
917-533-1469
Name
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2026-03-13
Name
Neueste SEC-Einreichungen
Name
ACXP's Discussions on Twitter

Compare ACXP vs VRTX, REGN, ARGX, ALNY, INSM

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
ACXP icon
ACXP
Acurx Pharmaceuticals Inc
3.54 10.51M 0 -7.97M -6.79M -3.8923
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
434.30 111.45B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
763.04 80.54B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
748.25 46.32B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
330.34 42.29B 3.71B 313.75M 465.38M 2.2571
INSM icon
INSM
Insmed Inc
163.81 35.01B 606.42M -1.28B -997.58M -6.403

Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten

pulisher
06:00 AM

Profit Recap: What is Acurx Pharmaceuticals Incs 5 year growth outlook2026 Winners & Losers & Fast Moving Trade Plans - baoquankhu1.vn

06:00 AM
pulisher
Apr 05, 2026

CEO Change: What are the risks of holding Acurx Pharmaceuticals IncEarnings Summary Report & Long-Term Growth Portfolio Plans - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 04, 2026

ACXP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

New to The Street Announces Episode 741 Airing Tonight on Bloomberg Television at 6:30 PM EST Featuring Canton Networks, Acme Markets, Virtuix Holdings (VTIX), HPB, Jonas & Redman, Acurx Pharmaceuticals (ACXP), and FreeCast (CAST) - ACCESS Newswire

Apr 04, 2026
pulisher
Apr 02, 2026

Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 02, 2026
pulisher
Apr 02, 2026

ACXP Forecast, Price Target & Analyst Ratings | ACURX PHARMACEUTICALS INC (NASDAQ:ACXP) - ChartMill

Apr 02, 2026
pulisher
Mar 31, 2026

ACXP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 31, 2026
pulisher
Mar 30, 2026

What is the dividend yield of Acurx Pharmaceuticals IncMarket Growth Report & Daily Stock Momentum Reports - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Acurx Pharmaceuticals Secures Korean Patent To Strengthen DNA Polymerase IIIC Inhibitor Portfolio - BioPharma APAC

Mar 30, 2026
pulisher
Mar 30, 2026

Earnings Report: Is Acurx Pharmaceuticals Inc stock undervalued right now2026 Trading Volume Trends & Reliable Price Breakout Signals - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

South Korea grants Acurx patent as it pushes new infection drugs - Stock Titan

Mar 30, 2026
pulisher
Mar 30, 2026

Day Trade: Can Acurx Pharmaceuticals Inc disrupt its industryProduct Launch & Low Drawdown Trading Strategies - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 28, 2026

Acurx Pharmaceuticals, Inc.Common Stock (Nasdaq:ACXP) Stock Quote - FinancialContent

Mar 28, 2026
pulisher
Mar 28, 2026

Can Acurx Pharmaceuticals (ACXP) climb 226.3% to reach the level Wall Street analysts expect? - msn.com

Mar 28, 2026
pulisher
Mar 24, 2026

Acurx Pharmaceuticals Inc (ACXP) Q4 2025 Earnings Call Highlights: Financial Growth and ... By GuruFocus - Investing.com Canada

Mar 24, 2026
pulisher
Mar 22, 2026

What's going on with Acurx Pharmaceuticals stock today? - MSN

Mar 22, 2026
pulisher
Mar 21, 2026

Why is Acurx Pharmaceuticals stock falling Thursday? - MSN

Mar 21, 2026
pulisher
Mar 19, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 19, 2026
pulisher
Mar 19, 2026

Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect? - sharewise.com

Mar 19, 2026
pulisher
Mar 19, 2026

Can Acurx Pharmaceuticals (ACXP) Surge by 226.3% to Meet the Target Set by Wall Street Analysts? - Bitget

Mar 19, 2026
pulisher
Mar 19, 2026

Can Acurx Pharmaceuticals (ACXP) Rise by 226.3% to Meet the Target Set by Wall Street Experts? - Bitget

Mar 19, 2026
pulisher
Mar 18, 2026

Acurx signals launch of pivotal recurrent CDI trial in H2 2026 while strengthening ibezapolstat pipeline - MSN

Mar 18, 2026
pulisher
Mar 17, 2026

Is Acurx Pharmaceuticals (ACXP) outperforming other medical stocks this year? - MSN

Mar 17, 2026
pulisher
Mar 17, 2026

Acurx Pharmaceuticals Drives Stock Surge with Major Clinical Developments​ - StocksToTrade

Mar 17, 2026
pulisher
Mar 17, 2026

Is Acurx Pharmaceuticals (ACXP) Surpassing Other Healthcare Stocks in Performance This Year? - Bitget

Mar 17, 2026
pulisher
Mar 17, 2026

Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Mar 17, 2026
pulisher
Mar 16, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 16, 2026
pulisher
Mar 15, 2026

Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Acurx Pharmaceuticals (ACXP) - The Globe and Mail

Mar 15, 2026
pulisher
Mar 14, 2026

What's Going On With Acurx Pharmaceuticals Stock Today? - Sahm

Mar 14, 2026
pulisher
Mar 14, 2026

Acurx Pharmaceuticals (ACXP) Gets a Buy from Alliance Global Partners - The Globe and Mail

Mar 14, 2026
pulisher
Mar 14, 2026

Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), BioLife Solutions (BLFS) - The Globe and Mail

Mar 14, 2026
pulisher
Mar 13, 2026

Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch - Investing.com Canada

Mar 13, 2026
pulisher
Mar 13, 2026

Acurx Pharmaceuticals (ACXP) Stock Rockets 218% as Phase 3 CDI Trial Gets Green Light - MEXC

Mar 13, 2026
pulisher
Mar 13, 2026

Acurx Pharmaceuticals, Inc. (ACXP) Stock: Reduces Net Loss While Expanding Ibezapolstat Clinical Program - parameter.io

Mar 13, 2026
pulisher
Mar 13, 2026

Acurx Pharmaceuticals Reports Full Year and Q4 Results, Provides Business Update - National Today

Mar 13, 2026
pulisher
Mar 13, 2026

Acurx Pharmaceuticals (ACXP) Stock Explodes 218% on CDI Clinical Trial Breakthrough - MEXC

Mar 13, 2026
pulisher
Mar 13, 2026

Acurx Pharma Stock Dips 9% Amid Market Volatility - timothysykes.com

Mar 13, 2026
pulisher
Mar 13, 2026

Acurx Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 13, 2026
pulisher
Mar 13, 2026

ACXP: Strong phase II results and new rCDI trial drive momentum amid improved financials - TradingView

Mar 13, 2026
pulisher
Mar 13, 2026

Earnings call transcript: Acurx Pharmaceuticals Q4 2025 reveals cash boost and R&D progress - Investing.com

Mar 13, 2026
pulisher
Mar 13, 2026

ACXP: Ibezapolstat progresses toward first-in-class status for rCDI, with strong results and new trials - TradingView

Mar 13, 2026
pulisher
Mar 13, 2026

Acurx Pharmaceuticals (ACXP) Stock Soars 218% Following Phase 3 CDI Trial Approval - parameter.io

Mar 13, 2026
pulisher
Mar 13, 2026

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Times Record News

Mar 13, 2026

Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):